David Battleman, MD, MBA

Principal & Founder, TrueNorth Lifesciences
Areas of expertise:

  • Development & Commercialization Strategy
  • Health Economics & Technology Assessment
  • Global Pricing & Market Access


Dr. Battleman is a seasoned healthcare executive with over 15 years of experience, spanning academia, industry and management consulting. Prior to establishing his advisory firm, TrueNorth Lifesciences, Dr. Battleman served as a senior principal in the R&D and commercial strategy practice within IMS Health Holdings, Inc., a Fortune 500 company providing data and consulting services to the global pharmaceutical industry. Prior to joining IMS Health, he was a management consultant at Bain & Company and executive director for Pfizer Pharmaceuticals. Within academia, he was assistant professor of Public Health & Medicine at Cornell University’s Weill Cornell Medical College. While at Cornell, Dr. Battleman’s research focused primarily on health economics and technology assessment and he has published both original research and expert reviews in these areas.

Dr. Battleman holds an M.D. from Weill Cornell Medical College, an M.B.A. from the University of Pennsylvania’s Wharton School of Business, and an M.Sc. from the Harvard School of Public Health. Dr. Battleman also holds his Series 63 & 82 licenses and, as mentioned, is a FINRA registered representative with Pickwick Capital Partners, LLC.

David Turner

Principal Advisor, TrueNorth Lifesciences
Areas of Expertise:

  • Investment Banking
  • Institutional Sales and Marketing
  • Investor Relations and Business Development


David Turner has 25 years of experience in finance with over 20 years spent working at JP Morgan, Lehman Brothers, and Macquarie Bank. During his career, Mr. Turner was responsible for investing, trading, and selling equities, derivatives, and structured products and was actively involved in all areas of capital markets including IPO and follow-on financings. For the majority of his career, Mr. Turner has been focused on international markets, with a significant focus in Asia, where he has worked with numerous companies to raise money and complete M&A activity in the United States. Mr. Turner has acted as an advisor to some of the largest institutional asset managers and hedge funds in the US helping place investments in overseas entities.

Mr. Turner is the founder Simon Venture Partners LLC where he worked with growth stage companies in the life sciences and technology sectors. He is a graduated from Yeshiva University with a B.S. in Economics and holds his Series 63 & 82 licenses as a FINRA registered representative with Pickwick Capital Partners, LLC.

Scott Korman

Principal Advisor, TrueNorth Lifesciences
Areas of Expertise:

  • Private Equity
  • Corporate Turnarounds & Restructuring
  • C-suite Operational Leadership


Scott Korman has been an active private equity principal and CEO. With 40 years of experience in entrepreneurship, leadership, creating vision and value, innovation and team building, Mr. Korman’s experience includes active participation on company boards of directors, capital raising, leading acquisitions, private equity fund and portfolio management and CEO roles. Mr. Korman has led private equity and venture capital transactions, strategic restructuring, complex negotiations, capital raising, closing investments and post-merger integration. As CEO, Mr. Korman has acted as principal, operating businesses and has deal-making expertise in start-up, growth stage, and mature companies.

Mr. Korman has led multiple acquisitions, corporate turnarounds of portfolio companies, investments in early stage businesses, served on both public and private corporate Boards of Directors and has raised several hundred million dollars of investment capital.

Jackie Nadile

Administrative Assistant, TrueNorth Lifesciences

Jackie is a graduate of the University of Southern California with a B.A. in cinematic arts. When not working with TrueNorth, Jackie is an aspiring movie producer and has worked as a production assistant for TV and film projects for HBO, NBCUniversal, Paramount, Showtime and Amazon.